Join the American Cancer Society National Lung Cancer Roundtable (NLCRT) for a monthly series, sponsored by AstraZeneca and Genentech, a member of the Roche Group, to narrow the knowledge gaps regarding the new lung cancer screening (LCS) eligibility criteria from the U.S. Preventive Services Task Force (USPSTF). The series begins on Wednesday, June 30, and will be held from 12 – 1 p.m.
Given the recent 2021 update of the USPSTF’s LCS recommendation, the NLCRT, in partnership with the American College of Radiology (ACR), the American Academy of Family Physicians, (AAFP), the American College of Chest Physicians (CHEST), and the American Thoracic Society (ATS), has created a seven-part webinar series, as well as a five-part podcast series, highlighting the recent recommendation and relevant issues for LCS. The goal is to promote equitable access LCS, narrow the knowledge gaps regarding screening eligibility criteria, and diminish disparities. This webinar series will feature perspectives from key stakeholder groups including patients, primary care physicians, pulmonologists, radiologists, epidemiologists, and behavioral scientists.
The webinar on Wednesday, June 30, will feature an update on LCS with a review of the expanded USPSTF LCS recommendation including, why the USPSTF recommendation was expanded and what the new criteria means for disparities, health equity, risk assessment, and reimbursement.
- NLCRT Chair Ella Kazerooni, MD, MS, from the University of Michigan,
- Thomas Houston, MD, member of the American Academy of Family Physicians,
- Melinda Aldrich, PhD, MPH, from Vanderbilt University, and
- a patient advocate.
- Wednesday, July 28
- Wednesday, August 25
- Wednesday, September 29
- Wednesday, October 6
- Wednesday, November 3
- Wednesday, November 17
Register online today!